Abstract
Complexes of lanthanum(III) with bis-coumarins: 3,
Complexes of lanthanum(III) with bis-coumarins: 3,
M E Marshall, J L Mohler, K Edmonds et al., “An updated review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin,” Journal of Cancer Research and Clinical Oncology, vol. 120, no. suppl, pp. S39–S42, 1994.
View at: Google ScholarE Moran, E Prosser, R O’Kennedy, and R D Thornes, “The effect of coumarin and 7-hydroxycoumarin on the growth of human tumor cell lines,” Journal of the Irish Colleges of Physicians & Surgeons, vol. 22, pp. 41–48, 1993.
View at: Google ScholarC P Siegers and H C Bostelmann, “Effect of coumarin on cell cycle proliferation in human tumor cell lines,” Journal of the Irish Colleges of Physicians & Surgeons, vol. 22, pp. 47–50, 1993.
View at: Google ScholarR B Myers, M Parker, and W E Grizzle, “The effects of coumarin and suramin on the growth of malignant renal and prostatic cell lines,” Journal of Cancer Research and Clinical Oncology, vol. 120, no. suppl 1, pp. S11–S13, 1994.
View at: Google ScholarG Feuer, J A Kellen, and K Kovacs, “Suppression of 7,12-dimethylbenz(alpha) anthracene-induced breast carcinoma by coumarin in the rat,” Oncology, vol. 33, no. 1, pp. 35–39, 1976.
View at: Google ScholarD Thornes, L Daly, G Lynch et al., “Prevention of early recurrence of high risk malignant melanoma by coumarin. Irish Melanoma Grou{p},” European Journal of Surgical Oncology, vol. 15, no. 5, pp. 431–435, 1989.
View at: Google ScholarB Omarbasha, W R Fair, and W D Heston, “Effect of coumarin on the normal rat prostate and on the R-3327H prostatic adenocarcinoma,” Cancer Research, vol. 49, no. 11, pp. 3045–3049, 1989.
View at: Google ScholarL D Raev, E Voinova, I C Ivanov, and D Popov, “Antitumor activity of some coumarin derivatives,” Die Pharmazie, vol. 45, no. 9, p. 696, 1990.
View at: Google ScholarA Maucher and E von Angerer, “Antitumour activity of coumarin and 7-hydroxycoumarin against 7,12-dimethylbenz[a] anthracene-induced rat mammary carcinomas,” Journal of Cancer Research and Clinical Oncology, vol. 120, no. 8, pp. 502–504, 1994.
View at: Google ScholarR D Thornes, L Daly, G Lynch et al., “Treatment with coumarin to prevent or delay recurrence of malignant melanoma,” Journal of Cancer Research and Clinical Oncology, vol. 120, no. suppl 1, pp. S32–S34, 1994.
View at: Google ScholarM E Marshall, K Butler, and A Fried, “Phase I evaluation of coumarin (1,2-benzopyrone) and cimetidine in patients with advanced malignancies,” Molecular Biotherapy, vol. 3, no. 3, pp. 170–178, 1991.
View at: Google ScholarJ L Mohler, L G Gomella, E D Crawford et al., “Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma,” The Prostate, vol. 20, no. 2, pp. 123–131, 1992.
View at: Google ScholarH Kolodziej, O Kayser, H J Woerdenbag, W van Uden, and N Pras, “Structure-cytotoxicity relationships of a series of natural and semi-synthetic simple coumarins as assessed in two human tumour cell lines,” Zeitschrift für Naturforschung C, vol. 52, no. 3-4, pp. 240–244, 1997.
View at: Google ScholarY M Issa, M M Omar, B A Sabrah, and S K Mohamed, “Complexes of cerium(III), thorium(IV)and dioxouranium(II) with 8-(arylazo)-7-hydroxy-4-methylcoumarin dyes,” Journal of the Indian Chemical Society, vol. 69, pp. 186–189, 1992.
View at: Google ScholarC Bisi Castellani and O Carugo, “Studies on fluorescent lanthanide complexes. New complexes of lanthanides(III) with coumarinic-3-carboxylic acid,” Inorganica Chimica Acta, vol. 159, no. 2, pp. 157–161, 1989.
View at: Google ScholarD Jiang, R Deng, and J Wu, “Synthesis and properties of lanthanide compounds of 3-sulfo-4-hy-droxycoumarin,” Wuji Huaxue, vol. 5, pp. 21–28, 1989.
View at: Google ScholarR Deng, J Wu, and L Long, “Lanthanide complexes of bis(4-hydroxy-3-coumarinyl) acetic acidand their anticoagulant action,” Bulletin des Sociétés Chimiques Belges, vol. 101, pp. 439–443, 1992.
View at: Google ScholarI Kostova, I Manolov, I Nicolova, S Konstantinov, and M Karaivanova, “New lanthanide complexes of 4-methyl-7-hydroxycoumarin and their pharmacological activity,” European Journal of Medicinal Chemistry, vol. 36, no. 4, pp. 339–347, 2001.
View at: Google ScholarI Kostova, I Manolov, S Konstantinov, and M Karaivanova, “Synthesis, physicochemical characterisation and cytotoxic screening of new complexes of cerium, lanthanum and neodymium with Warfarin and Coumachlor sodium salts,” European Journal of Medicinal Chemistry, vol. 34, no. 1, pp. 63–68, 1999.
View at: Google ScholarI Manolov, I Kostova, S Konstantinov, and M Karaivanova, “Synthesis, physicochemical characterization and cytotoxic screening of new complexes of cerium, lanthanum and neodymium with Niffcoumar sodium salt,” European Journal of Medicinal Chemistry, vol. 34, no. 10, pp. 853–858, 1999.
View at: Google ScholarI Manolov, I Kostova, T Netzeva, S Konstantinov, and M Karaivanova, “Cytotoxic activity of cerium complexes with coumarin derivatives. Molecular modeling of the ligands,” Archiv der Pharmazie: Pharmaceutical and Medicinal Chemistry, vol. 333, no. 4, pp. 93–98, 2000.
View at: Google ScholarI P Kostova, I I Manolov, I N Nicolova, and N D Danchev, “New metal complexes of 4-methyl-7-hydroxycoumarin sodium salt and their pharmacological activity,” Il Farmaco, vol. 56, no. 9, pp. 707–713, 2001.
View at: Google ScholarI Kostova, I Manolov, and M Karaivanova, “Synthesis, physicochemical characterization, and cytotoxic screening of new zirconium complexes with coumarin derivatives,” Archiv der Pharmazie: Pharmaceutical and Medicinal Chemistry, vol. 334, no. 5, pp. 157–162, 2001.
View at: Google ScholarI Kostova, I Manolov, and G Momekov, “Cytotoxic activity of new neodymium (III) complexes of bis-coumarins,” European Journal of Medicinal Chemistry, vol. 39, no. 9, pp. 765–775, 2004.
View at: Google ScholarT Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983.
View at: Google ScholarS M Konstantinov, H Eibl, and M R Berger, “BCR-ABL influences the antileukaemic efficacy of alkylphosphocholines,” British Journal of Haematology, vol. 107, no. 2, pp. 365–380, 1999.
View at: Google ScholarF D Lewis and S V Barancyk, “Lewis acid catalysis of photochemical reactions. 8. Photodimerization and cross-cycloaddition of coumarin,” Journal of the American Chemical Society, vol. 111, no. 23, pp. 8653–8661, 1989.
View at: Google ScholarI Kostova, N Trendafilova, and G Momekov, “Theoretical and spectroscopic evidence for coordination ability of 3,-benzylidenedi-4-hydroxycoumarin. New neodymium (III) complex and its cytotoxic effect,” Journal of Inorganic Biochemistry, vol. 99, no. 2, pp. 477–487, 2005.
View at: Google Scholar